Can a Washington resident get peptides by telehealth?
Washington adopted the Uniform Telehealth Act in 2024 (chapter 18.134 RCW). RCW 18.134.010 defines telehealth as the use of synchronous or asynchronous telecommunication technology by a practitioner to provide care to a patient at a different location, and excludes the use, in isolation, of email, instant messaging, text messaging, or fax. Under RCW 18.134.030 a practitioner-patient relationship may be established through telehealth, but not through email, instant messaging, text messaging, or fax. RCW 18.134.040 applies the same professional practice standards as comparable in-person care, including standards on prescribing, identity verification, documentation, and informed consent, and bars disciplining authorities from adopting a different standard for telehealth or limiting the technology that may be used. RCW 18.134.050 generally requires an out-of-state practitioner to hold a Washington license, with narrow exceptions for consultation, specialty assessment without treatment, and follow-up care of established patients temporarily in Washington. The Act does not mention online questionnaires by name. GLP-1 medicines and the peptides in this database are not controlled substances. This record classifies asynchronous prescribing as allowed because the statute says the relationship may be established through telehealth and defines telehealth to include asynchronous technology, so long as the care is not delivered only by email, instant messaging, text messaging, or fax and it meets the in-person standard of care. [2]
How does the Washington pharmacy board treat compounding?
| Board | Washington Pharmacy Quality Assurance Commission (Washington State Department of Health) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
In Washington the pharmacy regulator is a commission rather than a board: the Pharmacy Quality Assurance Commission (PQAC) regulates the practice of pharmacy and the distribution of drugs within and into the state under chapter 18.64 RCW and its consolidated rule chapter, WAC 246-945. WAC 246-945-100 requires every licensee that compounds sterile or non-sterile preparations to comply with the applicable USP chapters (795, 797, 800, and 825). RCW 18.64.360 requires nonresident pharmacies to be licensed and to submit a current inspection report from an approved state or third-party program; the Commission accepts reports from non-approved states only for pharmacies that do not compound. Washington has no separate state list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [3] [4] [5] [7]
Can you get compounded GLP-1s in Washington?
Because a nonresident pharmacy that compounds must supply an inspection report from an approved program to keep its Washington license, patients can confirm eligibility through the Department of Health provider credential search. [1] [4] [10]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Washington?
Access options
Prescriber licensed in Washington, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Washington. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
CJC-1295 / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $220/month
Tesamorelin / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $274/month
Semax / Selank from Bodybuilding Peptides
SponsoredPartner lists from $274/month
We may earn a commission from these links.
Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.
Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.
Find a provider in Washington
What you'll actually find in Washington, and how to check
Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [14] [15] [16]
No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [17]
What Washington has done
PeptideAgent has not found a board or legislative action on peptides in Washington.
Other states have acted:
- On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [19] Mississippi law
- Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [20] [21] Louisiana law
Checking the prescriber
Telehealth prescribing of non-controlled peptides is permitted in Washington. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. [2] The telehealth rule in full.
Checking the pharmacy
Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Washington Pharmacy Quality Assurance Commission (Washington State Department of Health); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [18]
If you're going ahead anyway
These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [17]
They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [8] [22] [23]
Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [18] [24] [25]
What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [16] [25] [26]
Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [17] [27] [28] [29] [30] [31]
Check for:
- A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [17]
- A real evaluation by a licensed prescriber, not just an online form.
- A certificate of analysis for the specific batch.
Questions to ask
- Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [18]
- Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [16]
- Pharmacy: Is this made for me on a prescription written in my name? [26]
- Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [16] [25]
- Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [16]
What is offered for a specific peptide, and what FDA found, is on each peptide page.
Is it legal to buy research peptides in Washington?
Chapter 69.41 RCW makes it unlawful to sell, deliver, or possess a legend (prescription) drug except on a valid prescription or as otherwise authorized (RCW 69.41.030), and pharmacy distribution into Washington requires Commission licensure under chapter 18.64 RCW. [3] [6] [11]
Peptide-specific notes for Washington
| Peptide | Note |
|---|---|
| BPC-157 | Not FDA approved and not on the 503A bulks list; its nomination was withdrawn in April 2026. On October 28, 2026 HHS released a draft enforcement discretion policy covering single-ingredient BPC-157 compounded by a state-licensed pharmacy by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's tested substance, with serious adverse events reported to FDA. It is not an FDA approval, is not binding, and does not cover blends such as Wolverine. FDA's drug center recommended against listing; the advisory committee voted in favor (HHS policy, Appendix B). The Pharmacy Quality Assurance Commission has not published a peptide-specific rule. [1] [8] [9] [12] [13] |
Frequently asked questions
Can I get a GLP-1 prescription in Washington through telehealth?
Yes. Under the Uniform Telehealth Act (chapter 18.134 RCW) a Washington-licensed practitioner can establish a relationship with you through telehealth and prescribe under the same standards as an in-person visit. [2]
Can a Washington telehealth relationship start over text or email?
No. RCW 18.134.030 says a practitioner-patient relationship may not be established through email, instant messaging, text messaging, or fax. The Act does define telehealth to include other asynchronous technology, and it does not mention online questionnaires by name. [2]
Does an out-of-state telehealth prescriber need a Washington license?
Generally yes. RCW 18.134.050 requires a Washington license, with narrow exceptions for consultation, specialty assessment that does not include treatment, and follow-up care for established patients who are temporarily in Washington. A new GLP-1 patient in Washington needs a Washington-licensed prescriber. [2]
What does an out-of-state compounding pharmacy need to ship to Washington?
A Washington nonresident pharmacy license under RCW 18.64.360, supported by a current inspection report from an approved state or third-party program. Pharmacies that compound cannot rely on reports from non-approved states, and all compounding must follow the USP chapters in WAC 246-945-100. [4] [5]
Is it legal to buy research peptides online in Washington?
Not for human use. RCW 69.41.030 bars selling or delivering a legend drug without a valid prescription, and "research use only" injectable peptides are unapproved new drugs under federal law that are not dispensed by a licensed pharmacy. [6] [11]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.
- [1]Washington Pharmacy Quality Assurance Commission (Department of Health)
- [2]Chapter 18.134 RCW, Uniform Telehealth Act
- [3]Chapter 18.64 RCW, Pharmacists
- [4]RCW 18.64.360, Nonresident pharmacies
- [5]Chapter 246-945 WAC, Pharmacy Quality Assurance Commission (including WAC 246-945-100, compounding minimum standards)
- [6]RCW 69.41.030, Sale, delivery, or possession of legend drug without prescription or order prohibited
- [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [8]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [9]FDA: Pharmacy Compounding Advisory CommitteeFDA
- [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, October 28). Are peptides legal in Washington?. https://peptideagent.ai/legal/washington- HTML link
<a href="https://peptideagent.ai/legal/washington">Are peptides legal in Washington?</a>, PeptideAgent, updated October 28, 2026.